Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full...
Na minha lista:
| Outros Autores: | |
|---|---|
| Formato: | Recurso Electrónico Capítulo de Livro |
| Idioma: | inglês |
| Publicado em: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Assuntos: | |
| Acesso em linha: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_87430 | ||
| 005 | 20220706 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220706s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-3882-2 | ||
| 020 | |a 9783036538815 | ||
| 020 | |a 9783036538822 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-3882-2 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 072 | 7 | |a TDCB |2 bicssc | |
| 100 | 1 | |a Drašar, Pavel B. |4 edt | |
| 700 | 1 | |a Drašar, Pavel B. |4 oth | |
| 245 | 1 | 0 | |a Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (334 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full papers in addition to five reviews. All of the published papers are a vibrant source of information on the therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 650 | 7 | |a Chemical engineering |2 bicssc | |
| 653 | |a Cannabis sativa (Cannabis) | ||
| 653 | |a cannabinoids | ||
| 653 | |a tetrahydrocannabinol (THC) | ||
| 653 | |a cannabidiol (CBD) | ||
| 653 | |a cannabinoid receptors (CB1 and CB2) | ||
| 653 | |a Papaver somniferum (opium poppy) | ||
| 653 | |a secondary metabolites | ||
| 653 | |a ursolic acid | ||
| 653 | |a NSCLC | ||
| 653 | |a tumorsphere | ||
| 653 | |a EGFR | ||
| 653 | |a STAT3 | ||
| 653 | |a MMP2 | ||
| 653 | |a PD-L1 | ||
| 653 | |a MAFLD | ||
| 653 | |a tanshinone IIA | ||
| 653 | |a phytochemical | ||
| 653 | |a lipogenesis | ||
| 653 | |a lipid accumulation | ||
| 653 | |a LXRα | ||
| 653 | |a malaria | ||
| 653 | |a quinine | ||
| 653 | |a chloroquine | ||
| 653 | |a artemisinin | ||
| 653 | |a onchocerciasis | ||
| 653 | |a ivermectin | ||
| 653 | |a moxidectin | ||
| 653 | |a cancer | ||
| 653 | |a vincristine | ||
| 653 | |a vinblastine | ||
| 653 | |a anabolic | ||
| 653 | |a diabetes | ||
| 653 | |a Duchenne muscular dystrophy | ||
| 653 | |a β-ecdysone | ||
| 653 | |a ecdysteroid | ||
| 653 | |a ecdysterone | ||
| 653 | |a Mas1 | ||
| 653 | |a osteoporosis | ||
| 653 | |a sarcopenia | ||
| 653 | |a COVID-19 | ||
| 653 | |a cardiometabolic diseases | ||
| 653 | |a respiratory diseases | ||
| 653 | |a natural product | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a lung cancer | ||
| 653 | |a United States Food and Drug Administration-approved drug | ||
| 653 | |a natural remedy | ||
| 653 | |a triterpenoid | ||
| 653 | |a molecular ribbon | ||
| 653 | |a Huisgen 1,3-dipolar cycloaddition | ||
| 653 | |a amide bond | ||
| 653 | |a multifunctional PEG3 derivative | ||
| 653 | |a antimicrobial activity | ||
| 653 | |a anti-HIV activity | ||
| 653 | |a cytotoxicity | ||
| 653 | |a supramolecular self-assembly | ||
| 653 | |a phytocannabinoids | ||
| 653 | |a cannabichromene | ||
| 653 | |a thermos-TRPs | ||
| 653 | |a TRPA1 | ||
| 653 | |a α,α-dimethylheptyl effect | ||
| 653 | |a betulinic acid | ||
| 653 | |a BODIPY | ||
| 653 | |a bevirimat | ||
| 653 | |a cell-cycle | ||
| 653 | |a fluorescent microscopy | ||
| 653 | |a maturation inhibitor | ||
| 653 | |a capsaicinoids | ||
| 653 | |a endocannabinoidome | ||
| 653 | |a microbiota | ||
| 653 | |a overweight | ||
| 653 | |a obesity | ||
| 653 | |a food intake | ||
| 653 | |a lipidomics | ||
| 653 | |a metabolism | ||
| 653 | |a alkaloids | ||
| 653 | |a membrane fusion | ||
| 653 | |a viral fusion inhibitor | ||
| 653 | |a antiviral therapy | ||
| 653 | |a curcumin | ||
| 653 | |a cancer cells | ||
| 653 | |a bioavailability | ||
| 653 | |a curcumin derivatives | ||
| 653 | |a curcumin analogues | ||
| 653 | |a curcumin delivery systems | ||
| 653 | |a natural product synthesis | ||
| 653 | |a lignans | ||
| 653 | |a inflammation | ||
| 653 | |a NF-κB inhibition | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5618 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/87430 |7 0 |z DOAB: description of the publication |